Publications
2021/02/09
Comparative Effectiveness Research in the Canadian Partnership for Tomorrow Cohort
Status
Ongoing
Start date
2012
Location
Quebec
Researcher
Bernatsky, Sasha
Associated institution
The Research Institute of the McGill University Health Centre and McGill University
Summary
This project uses data from CARTaGENE and Quebec administrative data to answer Health Canada’s questions about the safety and effectiveness of commonly prescribed medications. The analyses focus on three main areas:
Antidepressants (SSRIs/SNRIs): determining whether they increase the risk of fractures.
Hypertension: comparing the real‑world effectiveness of thiazide diuretics, which remain underused despite being effective and low‑cost.
Diabetes: evaluating the safety and impact of different types of insulin and oral treatments on hypoglycemia, blood sugar control (HbA1c), and weight.
This work helps health authorities better understand real‑world medication use and supports evidence‑based treatment policies for several chronic diseases.
Themes
- Chronic diseases
- Environment and lifestyle
- Public health and epidemiology
Data types
- Biochemical and hematological data
- Linked data
- Physical and cognitive measures
- Questionnaire data
Related resources
Publications
2021/01/10
Agreement in the CARTaGENE cohort between self-reported medication use and claim data
Theses and dissertations
2019
Estimating Rheumatoid Arthritis Prevalence and Care Quality in a Large Sample from the Quebec Population
Publications
2019/04/16
Care quality for rheumatoid arthritis patients in Quebec
Publications
2019/03/15
Identifying Rheumatoid Arthritis Cases Within the Quebec Health Administrative Database
Publications
2015/11/01